CD8A and neoplasm: Therefore, the ONP-302-induced tumor growth is a consequence of ONP-302 altering myeloid (44, 45), and Figures 1–3), NK cell, CD8+ T cell (Figures 4E, 5, 6), and tumor associated fibroblast function (45).Similar to the present findings, treatment of LLC tumor-bearing mice with ONP-302 significantly decreased tumor growth.